Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action
Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action is a paper indexed in PICO Portal from OpenAlex.
How many citations does Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action have?
Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action has 103 citations in the OpenAlex counts PICO Portal stores.
When was Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action published?
Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action has 2011 year in the PICO Portal index.
What is the open-access status of Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action?
Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action has closed oa status in the PICO Portal index.
What is the DOI of Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action?
The DOI for Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action is on the source record.
What is the PMID of Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action?
The PMID for Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action is on the source record.
What is the OpenAlex record for Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action?
The OpenAlex for Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action is on the source record.